(Q36728947)

15 August 2017

1 reference

title

Neuroendocrinological mechanisms of actions of antidepressant drugs (English)

1 reference

15 August 2017

Schüle C

1

1 reference

15 August 2017

publication date

1 March 2007

1 reference

Journal of Neuroendocrinology

15 August 2017

published in

1 reference

15 August 2017

volume

19

1 reference

15 August 2017

issue

3

1 reference

15 August 2017

page(s)

213-226

1 reference

The corticosteroid receptor hypothesis of depression

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Cortisol secretion in endogenous depression. I. Basal plasma levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Twenty-four-hour ACTH and cortisol pulsatility in depressed women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Cortisol, serotonin and depression: all stressed out?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Bio-social origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Adrenal gland enlargement in major depression. A computed tomographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Cortisol and corticosterone response after syn-corticotropin in relationship to dexamethasone suppressibility of cortisol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Adrenal cortical responses to low- and high-dose ACTH(1-24) administration in major depressives vs. matched controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Adrenal steroid type I and type II receptor binding: estimates of in vivo receptor number, occupancy, and activation with varying level of steroid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

The combined dexamethasone/CRH test as a potential surrogate marker in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

The influence of mirtazapine on anterior pituitary hormone secretion in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Some aspects of the neurotransmitter control of anterior pituitary function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Neuroendocrine probes of serotonergic function: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Adrenergic control of the secretion of anterior pituitary hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Modulation of 5-HT receptor subtype-mediated behaviours by corticosterone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Serotonergic regulation of renin and prolactin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Endocrinological responses to 5-HT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. A placebo-controlled evaluation of citalopram as 5-HT function probe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Effects of receptor blockers (methysergide, propranolol, phentolamine, yohimbine and prazosin) on desimipramine-induced pituitary hormone stimulation in humans--III. Hypothalamo-pituitary-adrenocortical axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Reboxetine acutely stimulates cortisol, ACTH, growth hormone and prolactin secretion in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Pharmacological evidence for inhibition of ACTH secretion by a central adrenergic system in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Acute reboxetine administration increases plasma and salivary cortisol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Sex differences in cortisol response to reboxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Endocrinological effects of mirtazapine in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Mirtazapine decreases stimulatory effects of reboxetine on cortisol, adrenocorticotropin and prolactin secretion in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Hypothalamic receptors influencing the secretion of corticotrophin releasing hormone in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Ziprasidone decreases cortisol excretion in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Influence of mirtazapine on salivary cortisol in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Influence of mirtazapine on urinary free cortisol excretion in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Antidepressive treatment with amitriptyline and paroxetine: effects on saliva cortisol concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Pulse-dosing and conventional application of doxepin: effects on psychopathology and hypothalamus-pituitary-adrenal (HPA) system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment--neurobiological and psychometric assessment of course

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

The combined DEX-CRH test in treatment course and long-term outcome of major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Clinical outcome after trimipramine in patients with delusional depression - a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Clinical and neurobiological effects of tianeptine and paroxetine in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Chronic antidepressant treatments decrease pro-opiomelanocortin mRNA expression in the pituitary gland: effects of acute stress and 5-HT(1A) receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

cAMP-dependent phosphorylation system after short and long-term administration of moclobemide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Four days of citalopram increase suppression of cortisol secretion by prednisolone in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Inhibition of P-glycoprotein by newer antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol (delta 9-THC): no influence on neuropsychological performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Do antidepressants regulate how cortisol affects the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-Glycoprotein gene disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Psychiatric implications of basic and clinical studies with corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Neuroendocrine effects of quetiapine in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

The DST as a predictor of outcome in depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

Adrenergic Blockade and the Corticosteroid and Growth Hormone Responses to Methylamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01516.X

10.1111/J.1365-2826.2006.01516.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference